Priority setting for pharmaceuticals - The use of health economic evidence by reimbursement and clinical guidance committees
(2004) In European Journal of Health Economics 5. p.28-35
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1385352
- author
- Anell, Anders LU
- publishing date
- 2004
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Journal of Health Economics
- volume
- 5
- pages
- 28 - 35
- publisher
- Springer
- external identifiers
-
- scopus:1542284169
- ISSN
- 1618-7601
- language
- English
- LU publication?
- no
- id
- 2a882fae-d0fb-4968-b6b4-5396d357b9eb (old id 1385352)
- date added to LUP
- 2016-04-04 13:48:12
- date last changed
- 2022-02-28 22:59:03
@article{2a882fae-d0fb-4968-b6b4-5396d357b9eb,
author = {{Anell, Anders}},
issn = {{1618-7601}},
language = {{eng}},
pages = {{28--35}},
publisher = {{Springer}},
series = {{European Journal of Health Economics}},
title = {{Priority setting for pharmaceuticals - The use of health economic evidence by reimbursement and clinical guidance committees}},
volume = {{5}},
year = {{2004}},
}